Diligence memo · auto-generated · as of July 3, 2026
Lewis & Clark Pharmaceuticals, Inc.
Lewis & Clark Pharmaceuticals, Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Lewis & Clark Pharmaceuticals, Inc. operates in Pharmaceuticals, based in CHARLOTTESVILLE.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Lewis & Clark Pharmaceuticals, Inc. has raised $725K in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $375K on 2012-11-06.
Most recent recorded round closed around 2012-11-06.
Valuation (modeled)modeled
Provath models Lewis & Clark Pharmaceuticals, Inc. at approximately $18M (range $210K–$201M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.94× the median modeled value of Pre-Seed Pharmaceuticals companies in 2010–2012 (71 peers) — value vs value, same stage and era. Within the normal band (94% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 13.6 yr ago; this sector typically re-raises about every 13 months.
Silent for over 3× the sector's normal cadence.
The last round was 1.1× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 15% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 26% of those peers.
Closest niche peers: Dermal Life, LLC, Armgo Pharma Inc, Third Day Healing Holdings LLC, Dermamedics Llc, China Yongxin Pharmaceuticals Inc..
Peoplefiled
5 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.